SlideShare a Scribd company logo
DEFINITION
Breast cancer is an abnormal proliferation of breast cell that results a
lump in the breast, change in breast shape, dimpling of the skin etc.
Breast cancer occurs at any where in the breast, but most
commonly found in the upper outer quadrant, where most breast tissues
are located.
INCIDENCE
 Breast cancer is the most common malignancy in Indian women
second only to the cervical cancer.
 1 in 28 Indian women is likely to develop breast cancer during her
lifetime. It is more for urban women (1 in 22) than the rural group (1
in 60).
TYPES
 NONINVASIVE CARCINOMA – An estimated 20% of all diagnosed breast cancers
are non-invasive.
 Ductal carcinoma in situ (DCIS)
 Lobular carcinoma in situ (LCIS)
 INVASIVE CARCINOMA –
 Infiltrating ductal carcinoma
 Mucinous carcinoma
 Medullary carcinoma
 Tubular carcinoma
 Infiltrating lobular carcinoma
 Inflammatory carcinoma
 Paget’s disease
DUCTAL CARCINOMA IN SITU
 Occurs when cancer fill the ducts but haven’t yet spread through the
walls into fatty tissue.
LOBULAR CARCINOMA IN SITU
 It develops in the cells of lobules the milk producing glands. It doesn’t spread
into nearby breast tissue, but can increases the risk of developing breast
cancer.
INFILTRATING DUCTAL CARCINOMA
 Most common histologic type of breast cancer.
 Found 80% of all cases.
 Tumors arise from the duct system and invade
the surrounding tissue.
MEDULLARY CARCINOMA
 5% cases
 Tends to be diagnosed more often in women younger than 50 years.
 The tumours grow in a capsule inside a duct.
MUCINOUS CARCINOMA
 3% cases found.
 Largely confined to the elderly population.
 Tends to grow slowly over years.
 Tumour cells are arranged in clusters and small islands of cells within large
lakes of mucin.
TUBULAR CARCINOMA
 Incidence is approximate 2%
 Most commonly diagnosed in the perimenopausal or early menopausal
population.
 Tumour consist of well formed tubules.
 Axillary metastases are rare.
 Excellent prognosis.
INVASIVE LOBULAR CARCINOMA
 Accounts for around 10% of cases.
 Arises from the lobular epithelium of the breast.
INFLAMMATORY CARCINOMA
 Very rare, accounts for about 1 – 3%.
 Most aggressive type and difficult to treat because it spreads rapidly.
 This is due to the malignant cells blocking the lymph channels in the skin.
PAGET’S DISEASE
 Represents about 1 – 2% of breast cancer.
 It stars in the milk ducts of nipple and can spread to the areola.
 Symptoms include scaly, erythematous, pruritic lesion of the nipple.
CAUSES & RISK FACTORS
 AGE
 More than 80% of breast cancer cases occur in women over 50 years.
 Uncommon before age 25years. Incidence increases to the time of
menopause and then slow down.
 FAMILY HISTORY
 Approx.10 % cases due to inherited genetic predisposition.
 Risk increases 2 – 3 times in 1st degree relatives compared to other
women.
 GENETIC FACTORS
 Mutation of tumour suppressor gene BRCA1 BRCA2 play a role in 5 – 10 %
of this case.
CONT..
 HISTORY OF OTHER CANCER
 HORMONAL FACTORS
 Increased levels of estrogen increases risk.
 Early menarche ( before 12 years)
 Late menopause (after 55 years)
 Nulliparity
 Late age at first child birth (after 30 years)
 Hormonal therapy, use of long term OCP
CONT..
 OTHERS
 High fat intake.
 Excess alcohol consumption
 Exposure to ionizing radiation
 Physical inactivity.
STAGING
 The American Joint Committee on Cancer (AJCC) has designated staging by
TNM.
 T = tumor size
 N = lymph node involvement
 M = metastasis
CONT..
STAGE TUMOR SIZE
(T)
NODAL INVOLVMENT
(N)
METASTASIS
(M)
0 Carcinoma in situ No No
I ≤ 2 cm No No
II >2 cm but ≤ 5 cm No / 1 – 3 axillary lymph node No
III A No evidence of tumor ranging to > 5cm Yes, 4 – 9 axillary / internal
mammary lymph node
No
III B Any size with extension to chest wall
or skin.
Yes, 4 – 9 axillary / internal
mammary lymph node
No
III C Any size Yes, >10 axillary, internal
mammary, infraclavicular
nodes
No
IV Any size Any type of nodal involvement Yes
CLINICAL MANIFESTATIONS
 Any unusual changes in the breast can be a symptom of breast cancer.
 A lump or thickening in the breast.
 Breast pain and tenderness.
 Redness, scaliness or thickening of the nipple or beast skin.
 Nipple pain and nipple turning inward.
 Discharge from nipple.
 Skin irritation and dimpling.
 Enlarged axillary and supraclavicular lymph nodes.
DIAGNOSTIC STUDIES
 History taking including risk factors.
 Physical examination.
 Imaging techniques
 Breast ultrasound
 Mammography
 Breast MRI
 Biopsy: When a lump can be felt and is suspicious for cancer on mammography.
 FNAC
 Incisional biopsy
 Excisional biopsy
 Ultrasound core biopsy
MANAGEMENT
ADJUVANT THERAPY
 Treatment that is given in addition to primary (initial) treatment.
 It is an addition designed to help to reach the ultimate goal.
 Adjuvant therapy for cancer usually refers to surgery followed by chemo or
radiotherapy to help to decrease the risk of cancer recurring.
SURGICAL MANAGEMENT
 MASTECTOMY: An operation to remove the breast is called mastectomy. There
are five different types of mastectomy.
 Simple or total mastectomy
 Modified radical mastectomy
 Radical mastectomy
 Partial mastectomy
 Nipple sparing mastectomy
 Lymph node dissection
 Cryotherapy
 Breast reconstructive surgery
 Prophylactic ovary removal
SIMPLE / TOTAL MASTECTOMY
 The surgeon removes the entire breast.
 Does not perform axillary lymph node
dissection.
 No muscles are removed from beneath the
breast.
 It is appropriate for women with multiple or
large areas of ductal carcinoma in situ (DCIS).
MODIFIED RADICAL MASTECTOMY
 The surgeon removes the entire breast.
 Axillary lymph node dissection is performed,
during which level I & II underarm lymph nodes
are removed.
 No muscles are removed from beneath the
breast.
 It is appropriate for women with invasive
breast cancer.
RADICAL MASTECTOMY
 Entire breast should be removed.
 Levels I, II & III of the underarm lymph nodes
are removed.
 The surgeon also removes the chest wall
muscle under the breast.
 It is recommended only when the breast
cancer has spread to the chest muscles under
the breast.
CONT..
 PARTIAL MASTECTOMY - It is the removal of
cancerous part of the breast tissue and
some normal tissue around it.
 NIPPLE SPARING MASTECTOMY – All of the
breast tissue is removed here, only the
nipple is left alone.
CONT..
 CRYOSURGERY - Uses extreme cold to
freeze and kill the cancer cells.
 BREAST RECONSTRUCTIVE SURGERY –
Rebuilding of the breast after mastectomy
or sometimes lumpectomy.
TYPES
 Prosthetic implant
 Autologous tissue reconstructions
MEDICAL MANAGEMENT
RADIATION THERAPY – most women receive radiation therapy after breast
sparing surgery. Sometimes it can be used as primary treatment. Radiation
destroys cancer cell that may remain in area.
TYPES
 External radiation
 Internal radiation (Brachytherapy)
CONT..
CHEMOTHERAPY –
 Refers to use of cytotoxic drugs to destroy the cancer cell.
 In some patient it is used preoperatively which decreases the size of the
primary tumor, possibly permitting less extensive surgery.
 Most common combinations of chemotherapy are –
 CMF – Cyclophosphamide, Methotrexate, 5 fluorouracil
 CEF – Cyclophosphamide, Epirubicin, 5 fluorouracil
 Treatments are given every 3 – 4 weeks for 6 – 9 months.
CONT..
HORMONAL THERAPY –
 Recommended for all estrogen receptor positive patient.
 Hormonal therapy blocks the source of estrogen thus promoting tumor
regression.
 Anastrozole, tamoxifen etc most commonly used.
BIOTHERAPY –
 Helps to strengthen the immune system to fight against the cancer.
 Can be used alone or combined with chemotherapy.
 Transtuzumab is a monoclonal antibody most commonly used.
NURSING MANAGEMENT
 PREOPERATIVE MANAGEMENT
 POSEOPERATIVE MANAGEMENT
NURSING DIAGNOSIS
 Ineffective individual coping and compromised family coping related to
diagnosis of cancer and surgical changes in breast as evidenced by facial mask
of fear and frequent asking of questions.
 Acute pain related to surgical incision as evidenced by verbalization of pain at
surgical site.
 Fluid electrolyte imbalance related to NPM status of patient / less intake by
the patient or presence of surgical drainage system as evidenced by dry lip,
dry mouth.
CONT..
 Impaired physical mobility related to weakness and muscular loss as
evidenced by limitation in movement of upper extremity on surgical site.
 High risk for infection related to surgical incision, presence of drainage
system.
 Risk for impaired skin integrity related to surgery or radiation therapy.
 Disturbed body image related to mastectomy as evidenced by verbalization of
concern about appearance & feelings of loss of femineity.
POST MASTECTOMY EXERCISE
HAND WALL CLIMBING
 Stand facing wall with toes 6 – 12 inches from
wall.
 Bend elbows and place arms against wall at
shoulder level.
 Gradually move both hands up the wall parallel to
each other until feel pain or pull in incision.
CONT..
ROPE TURNING
 Tie rope to the door handle.
 Hold rope in hand of operated side,
 Back from door until arm is extended away from
body, parallel to floor.
 Swing rope to make a circle as wide as possible.
CONT..
ROD OR BROOMSTICK LIFTING
 Grasp a rod with both hands, held about 2 feet
apart.
 Keeping the arm straight, raise the rod over the
head.
 Bend elbows to lower the rod behind the head.
 Reverse maneuver, raising the rod above the
head, then return to the starting position.
CONT..
PULLEY TUGGING
 Toss a light rope over curtain rod.
 Hold the ends of the rope in each hand.
 Slowly raise operated arm as comfortable by pulling
down the rope on opposite side.
 Reverse raise the unoperated arm by lowering the
operated side.
 Instead of rope towel can be used as it is used to
clean the back of our body.
CONT..
ELBOW CIRCLES
 While on sitting or standing position. Put your
right hand on right shoulder and left hand on
left shoulder.
 Raise the elbows until you feel a stretch and
make circles with the elbows.
 Start with small then make longer circles.
 Change directions of circles and repeat 2 – 3
times.
THANK YOU

More Related Content

What's hot

Chemotherapy of breast cancer
Chemotherapy of breast cancerChemotherapy of breast cancer
Chemotherapy of breast cancer
Dr Sachin Prakash
 
Breast Cancer.ppt
Breast Cancer.pptBreast Cancer.ppt
Breast Cancer.pptShama
 
Drugs used or avoided in pregnancy
Drugs used or avoided in pregnancyDrugs used or avoided in pregnancy
Drugs used or avoided in pregnancy
mostafa hosni
 
Endometrial carcinoma.lecture by Associate Professor Dr Aisha Elbareg
Endometrial carcinoma.lecture by Associate Professor Dr Aisha ElbaregEndometrial carcinoma.lecture by Associate Professor Dr Aisha Elbareg
Endometrial carcinoma.lecture by Associate Professor Dr Aisha Elbareg
Dr. Aisha M Elbareg
 
Uterine cancer (Endometrial & Cervical Cancer)
Uterine cancer (Endometrial & Cervical Cancer)Uterine cancer (Endometrial & Cervical Cancer)
Uterine cancer (Endometrial & Cervical Cancer)
FarazaJaved
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
Uma Chidiebere
 
Gynecomastia
GynecomastiaGynecomastia
Gynecomastia
Dr. Lala Shourav Das
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
Abhay Rajpoot
 
Ovarian Cancer
Ovarian CancerOvarian Cancer
Ovarian Cancer
Abhay Rajpoot
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
Nidhi Chauhan
 
breast cancer
breast cancerbreast cancer
breast cancer
alekhya palle
 
Hormonal therapy in breast cancer
Hormonal therapy in breast cancerHormonal therapy in breast cancer
Hormonal therapy in breast cancer
DrAyush Garg
 
Treatment of CA Ovary
Treatment of CA OvaryTreatment of CA Ovary
Treatment of CA Ovary
Anil Gupta
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
Snehlata Parashar
 
Breast cancer ppt
Breast cancer pptBreast cancer ppt
Breast cancer pptdrizsyed
 
Ovarian cancer ppt
Ovarian cancer pptOvarian cancer ppt
Ovarian cancer ppt
Vidya Dhonde
 
Endometrial Carcinoma
Endometrial Carcinoma Endometrial Carcinoma
Endometrial Carcinoma
Abdullatif Al-Rashed
 
Esophageal Cancer
Esophageal CancerEsophageal Cancer
Esophageal Cancer
DJ CrissCross
 
BREAST CANCER PPT
BREAST CANCER PPTBREAST CANCER PPT
BREAST CANCER PPT
Rajkumarshingnath
 

What's hot (20)

Chemotherapy of breast cancer
Chemotherapy of breast cancerChemotherapy of breast cancer
Chemotherapy of breast cancer
 
Breast Cancer.ppt
Breast Cancer.pptBreast Cancer.ppt
Breast Cancer.ppt
 
Drugs used or avoided in pregnancy
Drugs used or avoided in pregnancyDrugs used or avoided in pregnancy
Drugs used or avoided in pregnancy
 
Endometrial carcinoma.lecture by Associate Professor Dr Aisha Elbareg
Endometrial carcinoma.lecture by Associate Professor Dr Aisha ElbaregEndometrial carcinoma.lecture by Associate Professor Dr Aisha Elbareg
Endometrial carcinoma.lecture by Associate Professor Dr Aisha Elbareg
 
Uterine cancer (Endometrial & Cervical Cancer)
Uterine cancer (Endometrial & Cervical Cancer)Uterine cancer (Endometrial & Cervical Cancer)
Uterine cancer (Endometrial & Cervical Cancer)
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
 
Gynecomastia
GynecomastiaGynecomastia
Gynecomastia
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
 
Ovarian Cancer
Ovarian CancerOvarian Cancer
Ovarian Cancer
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
 
breast cancer
breast cancerbreast cancer
breast cancer
 
Hormonal therapy in breast cancer
Hormonal therapy in breast cancerHormonal therapy in breast cancer
Hormonal therapy in breast cancer
 
Treatment of CA Ovary
Treatment of CA OvaryTreatment of CA Ovary
Treatment of CA Ovary
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
Breast cancer ppt
Breast cancer pptBreast cancer ppt
Breast cancer ppt
 
Ovarian cancer ppt
Ovarian cancer pptOvarian cancer ppt
Ovarian cancer ppt
 
Endometrial Carcinoma
Endometrial Carcinoma Endometrial Carcinoma
Endometrial Carcinoma
 
Prostate cancer
Prostate cancerProstate cancer
Prostate cancer
 
Esophageal Cancer
Esophageal CancerEsophageal Cancer
Esophageal Cancer
 
BREAST CANCER PPT
BREAST CANCER PPTBREAST CANCER PPT
BREAST CANCER PPT
 

Similar to BREAST CANCER_074427.pptx

Breast cancer
Breast cancerBreast cancer
Breast cancer
Victoria Fernandez
 
Breast cancer ppt med surg
Breast cancer ppt med surgBreast cancer ppt med surg
Breast cancer ppt med surg
NehaNupur8
 
Breast cancer hegazy
Breast cancer hegazyBreast cancer hegazy
Breast cancer hegazy
mostafa hegazy
 
BREAST CANCER.docx
BREAST CANCER.docxBREAST CANCER.docx
BREAST CANCER.docx
DendenDianaCharaMoyo
 
4. Cellular Aberration
4. Cellular Aberration   4. Cellular Aberration
4. Cellular Aberration
Abigail Abalos
 
Breast Carcinoma pakistan.pptx
Breast Carcinoma pakistan.pptxBreast Carcinoma pakistan.pptx
Breast Carcinoma pakistan.pptx
Jawad Awan
 
breast cancer ppt (1).pptx
breast cancer ppt (1).pptxbreast cancer ppt (1).pptx
breast cancer ppt (1).pptx
SURAJVERMA624032
 
BREST CARSINOMA and its anatomy,resources.pptx
BREST CARSINOMA and its anatomy,resources.pptxBREST CARSINOMA and its anatomy,resources.pptx
BREST CARSINOMA and its anatomy,resources.pptx
omkarnunna1
 
4 cellularaberration-biologyofcancer-120713193827-phpapp01
4 cellularaberration-biologyofcancer-120713193827-phpapp014 cellularaberration-biologyofcancer-120713193827-phpapp01
4 cellularaberration-biologyofcancer-120713193827-phpapp01Cristine Keith Escobar
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
AnniaRamos
 
Breast cancer pathology
Breast cancer pathologyBreast cancer pathology
Breast cancer pathology
kiran imtiaz
 
carcinoma of breast
carcinoma of breastcarcinoma of breast
carcinoma of breast
dr sajid Abbasi
 
Presentation1.pptx, radiological imaging of malignant breast diseases.
Presentation1.pptx, radiological imaging of malignant breast diseases.Presentation1.pptx, radiological imaging of malignant breast diseases.
Presentation1.pptx, radiological imaging of malignant breast diseases.Abdellah Nazeer
 
breastca-121013104443-phpapp01
breastca-121013104443-phpapp01breastca-121013104443-phpapp01
breastca-121013104443-phpapp01Ali Adnan
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
Zahraa Samer
 
Mx of breast cancer
Mx of breast cancer  Mx of breast cancer
Mx of breast cancer
Osama Ali
 
breastcancer breast cancer cancer ca.ppt
breastcancer breast cancer cancer ca.pptbreastcancer breast cancer cancer ca.ppt
breastcancer breast cancer cancer ca.ppt
Zellanienhd
 

Similar to BREAST CANCER_074427.pptx (20)

Breast cancer
Breast cancerBreast cancer
Breast cancer
 
Breast cancer ppt med surg
Breast cancer ppt med surgBreast cancer ppt med surg
Breast cancer ppt med surg
 
Breast cancer hegazy
Breast cancer hegazyBreast cancer hegazy
Breast cancer hegazy
 
BREAST CANCER.docx
BREAST CANCER.docxBREAST CANCER.docx
BREAST CANCER.docx
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
 
4. Cellular Aberration
4. Cellular Aberration   4. Cellular Aberration
4. Cellular Aberration
 
Breast Carcinoma pakistan.pptx
Breast Carcinoma pakistan.pptxBreast Carcinoma pakistan.pptx
Breast Carcinoma pakistan.pptx
 
breast cancer ppt (1).pptx
breast cancer ppt (1).pptxbreast cancer ppt (1).pptx
breast cancer ppt (1).pptx
 
BREST CARSINOMA and its anatomy,resources.pptx
BREST CARSINOMA and its anatomy,resources.pptxBREST CARSINOMA and its anatomy,resources.pptx
BREST CARSINOMA and its anatomy,resources.pptx
 
4 cellularaberration-biologyofcancer-120713193827-phpapp01
4 cellularaberration-biologyofcancer-120713193827-phpapp014 cellularaberration-biologyofcancer-120713193827-phpapp01
4 cellularaberration-biologyofcancer-120713193827-phpapp01
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
 
Breast cancer pathology
Breast cancer pathologyBreast cancer pathology
Breast cancer pathology
 
carcinoma of breast
carcinoma of breastcarcinoma of breast
carcinoma of breast
 
Presentation1.pptx, radiological imaging of malignant breast diseases.
Presentation1.pptx, radiological imaging of malignant breast diseases.Presentation1.pptx, radiological imaging of malignant breast diseases.
Presentation1.pptx, radiological imaging of malignant breast diseases.
 
E uterus
E uterusE uterus
E uterus
 
breastca-121013104443-phpapp01
breastca-121013104443-phpapp01breastca-121013104443-phpapp01
breastca-121013104443-phpapp01
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
 
Mx of breast cancer
Mx of breast cancer  Mx of breast cancer
Mx of breast cancer
 
breastcancer breast cancer cancer ca.ppt
breastcancer breast cancer cancer ca.pptbreastcancer breast cancer cancer ca.ppt
breastcancer breast cancer cancer ca.ppt
 
Benign breast disease dr mnr
Benign breast disease dr mnrBenign breast disease dr mnr
Benign breast disease dr mnr
 

More from ShubhrimaKhan

HIV AIDS_124217.pptx
HIV AIDS_124217.pptxHIV AIDS_124217.pptx
HIV AIDS_124217.pptx
ShubhrimaKhan
 
Plural effusion_092054.pptx
Plural effusion_092054.pptxPlural effusion_092054.pptx
Plural effusion_092054.pptx
ShubhrimaKhan
 
PNEUMOTHORAX_075811.pptx
PNEUMOTHORAX_075811.pptxPNEUMOTHORAX_075811.pptx
PNEUMOTHORAX_075811.pptx
ShubhrimaKhan
 
ASTHMA_012154.pptx
ASTHMA_012154.pptxASTHMA_012154.pptx
ASTHMA_012154.pptx
ShubhrimaKhan
 
ARDS , RESPIRATORY FAILURE_085830.pptx
ARDS , RESPIRATORY FAILURE_085830.pptxARDS , RESPIRATORY FAILURE_085830.pptx
ARDS , RESPIRATORY FAILURE_085830.pptx
ShubhrimaKhan
 
ASTHMA_012154.pptx
ASTHMA_012154.pptxASTHMA_012154.pptx
ASTHMA_012154.pptx
ShubhrimaKhan
 
Lung abscess_102210.pptx
Lung abscess_102210.pptxLung abscess_102210.pptx
Lung abscess_102210.pptx
ShubhrimaKhan
 
Spinal cord injury_040036.pptx
Spinal cord injury_040036.pptxSpinal cord injury_040036.pptx
Spinal cord injury_040036.pptx
ShubhrimaKhan
 
COPD
COPDCOPD
GB syndrome_015823.pptx
GB syndrome_015823.pptxGB syndrome_015823.pptx
GB syndrome_015823.pptx
ShubhrimaKhan
 
Plural effusion, PE & lung abscess, pneumothorax_014402.pptx
Plural effusion, PE & lung abscess, pneumothorax_014402.pptxPlural effusion, PE & lung abscess, pneumothorax_014402.pptx
Plural effusion, PE & lung abscess, pneumothorax_014402.pptx
ShubhrimaKhan
 
multiple sclerosis_063233.pptx
multiple sclerosis_063233.pptxmultiple sclerosis_063233.pptx
multiple sclerosis_063233.pptx
ShubhrimaKhan
 
LRTIs_025720.pptx
LRTIs_025720.pptxLRTIs_025720.pptx
LRTIs_025720.pptx
ShubhrimaKhan
 
Gatekeeper training programme on mental health royal college of nursing.pptx
Gatekeeper training programme on mental health royal college of nursing.pptxGatekeeper training programme on mental health royal college of nursing.pptx
Gatekeeper training programme on mental health royal college of nursing.pptx
ShubhrimaKhan
 
UPPER RESPIRATORY TRACT INFECTIONS_015624.pptx
UPPER RESPIRATORY TRACT INFECTIONS_015624.pptxUPPER RESPIRATORY TRACT INFECTIONS_015624.pptx
UPPER RESPIRATORY TRACT INFECTIONS_015624.pptx
ShubhrimaKhan
 
EXPERIMENTAL DESIGN.pptx
EXPERIMENTAL DESIGN.pptxEXPERIMENTAL DESIGN.pptx
EXPERIMENTAL DESIGN.pptx
ShubhrimaKhan
 
Webiner.pptx
Webiner.pptxWebiner.pptx
Webiner.pptx
ShubhrimaKhan
 
Dissertation
DissertationDissertation
Dissertation
ShubhrimaKhan
 
Respiratory_Tract_Infection
Respiratory_Tract_Infection Respiratory_Tract_Infection
Respiratory_Tract_Infection
ShubhrimaKhan
 
pain_103744.pptx
pain_103744.pptxpain_103744.pptx
pain_103744.pptx
ShubhrimaKhan
 

More from ShubhrimaKhan (20)

HIV AIDS_124217.pptx
HIV AIDS_124217.pptxHIV AIDS_124217.pptx
HIV AIDS_124217.pptx
 
Plural effusion_092054.pptx
Plural effusion_092054.pptxPlural effusion_092054.pptx
Plural effusion_092054.pptx
 
PNEUMOTHORAX_075811.pptx
PNEUMOTHORAX_075811.pptxPNEUMOTHORAX_075811.pptx
PNEUMOTHORAX_075811.pptx
 
ASTHMA_012154.pptx
ASTHMA_012154.pptxASTHMA_012154.pptx
ASTHMA_012154.pptx
 
ARDS , RESPIRATORY FAILURE_085830.pptx
ARDS , RESPIRATORY FAILURE_085830.pptxARDS , RESPIRATORY FAILURE_085830.pptx
ARDS , RESPIRATORY FAILURE_085830.pptx
 
ASTHMA_012154.pptx
ASTHMA_012154.pptxASTHMA_012154.pptx
ASTHMA_012154.pptx
 
Lung abscess_102210.pptx
Lung abscess_102210.pptxLung abscess_102210.pptx
Lung abscess_102210.pptx
 
Spinal cord injury_040036.pptx
Spinal cord injury_040036.pptxSpinal cord injury_040036.pptx
Spinal cord injury_040036.pptx
 
COPD
COPDCOPD
COPD
 
GB syndrome_015823.pptx
GB syndrome_015823.pptxGB syndrome_015823.pptx
GB syndrome_015823.pptx
 
Plural effusion, PE & lung abscess, pneumothorax_014402.pptx
Plural effusion, PE & lung abscess, pneumothorax_014402.pptxPlural effusion, PE & lung abscess, pneumothorax_014402.pptx
Plural effusion, PE & lung abscess, pneumothorax_014402.pptx
 
multiple sclerosis_063233.pptx
multiple sclerosis_063233.pptxmultiple sclerosis_063233.pptx
multiple sclerosis_063233.pptx
 
LRTIs_025720.pptx
LRTIs_025720.pptxLRTIs_025720.pptx
LRTIs_025720.pptx
 
Gatekeeper training programme on mental health royal college of nursing.pptx
Gatekeeper training programme on mental health royal college of nursing.pptxGatekeeper training programme on mental health royal college of nursing.pptx
Gatekeeper training programme on mental health royal college of nursing.pptx
 
UPPER RESPIRATORY TRACT INFECTIONS_015624.pptx
UPPER RESPIRATORY TRACT INFECTIONS_015624.pptxUPPER RESPIRATORY TRACT INFECTIONS_015624.pptx
UPPER RESPIRATORY TRACT INFECTIONS_015624.pptx
 
EXPERIMENTAL DESIGN.pptx
EXPERIMENTAL DESIGN.pptxEXPERIMENTAL DESIGN.pptx
EXPERIMENTAL DESIGN.pptx
 
Webiner.pptx
Webiner.pptxWebiner.pptx
Webiner.pptx
 
Dissertation
DissertationDissertation
Dissertation
 
Respiratory_Tract_Infection
Respiratory_Tract_Infection Respiratory_Tract_Infection
Respiratory_Tract_Infection
 
pain_103744.pptx
pain_103744.pptxpain_103744.pptx
pain_103744.pptx
 

Recently uploaded

aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
timhan337
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 

Recently uploaded (20)

aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 

BREAST CANCER_074427.pptx

  • 1.
  • 2. DEFINITION Breast cancer is an abnormal proliferation of breast cell that results a lump in the breast, change in breast shape, dimpling of the skin etc. Breast cancer occurs at any where in the breast, but most commonly found in the upper outer quadrant, where most breast tissues are located.
  • 3. INCIDENCE  Breast cancer is the most common malignancy in Indian women second only to the cervical cancer.  1 in 28 Indian women is likely to develop breast cancer during her lifetime. It is more for urban women (1 in 22) than the rural group (1 in 60).
  • 4. TYPES  NONINVASIVE CARCINOMA – An estimated 20% of all diagnosed breast cancers are non-invasive.  Ductal carcinoma in situ (DCIS)  Lobular carcinoma in situ (LCIS)  INVASIVE CARCINOMA –  Infiltrating ductal carcinoma  Mucinous carcinoma  Medullary carcinoma  Tubular carcinoma  Infiltrating lobular carcinoma  Inflammatory carcinoma  Paget’s disease
  • 5. DUCTAL CARCINOMA IN SITU  Occurs when cancer fill the ducts but haven’t yet spread through the walls into fatty tissue.
  • 6. LOBULAR CARCINOMA IN SITU  It develops in the cells of lobules the milk producing glands. It doesn’t spread into nearby breast tissue, but can increases the risk of developing breast cancer.
  • 7. INFILTRATING DUCTAL CARCINOMA  Most common histologic type of breast cancer.  Found 80% of all cases.  Tumors arise from the duct system and invade the surrounding tissue.
  • 8. MEDULLARY CARCINOMA  5% cases  Tends to be diagnosed more often in women younger than 50 years.  The tumours grow in a capsule inside a duct.
  • 9. MUCINOUS CARCINOMA  3% cases found.  Largely confined to the elderly population.  Tends to grow slowly over years.  Tumour cells are arranged in clusters and small islands of cells within large lakes of mucin.
  • 10. TUBULAR CARCINOMA  Incidence is approximate 2%  Most commonly diagnosed in the perimenopausal or early menopausal population.  Tumour consist of well formed tubules.  Axillary metastases are rare.  Excellent prognosis.
  • 11. INVASIVE LOBULAR CARCINOMA  Accounts for around 10% of cases.  Arises from the lobular epithelium of the breast.
  • 12. INFLAMMATORY CARCINOMA  Very rare, accounts for about 1 – 3%.  Most aggressive type and difficult to treat because it spreads rapidly.  This is due to the malignant cells blocking the lymph channels in the skin.
  • 13. PAGET’S DISEASE  Represents about 1 – 2% of breast cancer.  It stars in the milk ducts of nipple and can spread to the areola.  Symptoms include scaly, erythematous, pruritic lesion of the nipple.
  • 14. CAUSES & RISK FACTORS  AGE  More than 80% of breast cancer cases occur in women over 50 years.  Uncommon before age 25years. Incidence increases to the time of menopause and then slow down.  FAMILY HISTORY  Approx.10 % cases due to inherited genetic predisposition.  Risk increases 2 – 3 times in 1st degree relatives compared to other women.  GENETIC FACTORS  Mutation of tumour suppressor gene BRCA1 BRCA2 play a role in 5 – 10 % of this case.
  • 15. CONT..  HISTORY OF OTHER CANCER  HORMONAL FACTORS  Increased levels of estrogen increases risk.  Early menarche ( before 12 years)  Late menopause (after 55 years)  Nulliparity  Late age at first child birth (after 30 years)  Hormonal therapy, use of long term OCP
  • 16. CONT..  OTHERS  High fat intake.  Excess alcohol consumption  Exposure to ionizing radiation  Physical inactivity.
  • 17. STAGING  The American Joint Committee on Cancer (AJCC) has designated staging by TNM.  T = tumor size  N = lymph node involvement  M = metastasis
  • 18.
  • 19. CONT.. STAGE TUMOR SIZE (T) NODAL INVOLVMENT (N) METASTASIS (M) 0 Carcinoma in situ No No I ≤ 2 cm No No II >2 cm but ≤ 5 cm No / 1 – 3 axillary lymph node No III A No evidence of tumor ranging to > 5cm Yes, 4 – 9 axillary / internal mammary lymph node No III B Any size with extension to chest wall or skin. Yes, 4 – 9 axillary / internal mammary lymph node No III C Any size Yes, >10 axillary, internal mammary, infraclavicular nodes No IV Any size Any type of nodal involvement Yes
  • 20. CLINICAL MANIFESTATIONS  Any unusual changes in the breast can be a symptom of breast cancer.  A lump or thickening in the breast.  Breast pain and tenderness.  Redness, scaliness or thickening of the nipple or beast skin.  Nipple pain and nipple turning inward.  Discharge from nipple.  Skin irritation and dimpling.  Enlarged axillary and supraclavicular lymph nodes.
  • 21. DIAGNOSTIC STUDIES  History taking including risk factors.  Physical examination.  Imaging techniques  Breast ultrasound  Mammography  Breast MRI  Biopsy: When a lump can be felt and is suspicious for cancer on mammography.  FNAC  Incisional biopsy  Excisional biopsy  Ultrasound core biopsy
  • 22.
  • 23. MANAGEMENT ADJUVANT THERAPY  Treatment that is given in addition to primary (initial) treatment.  It is an addition designed to help to reach the ultimate goal.  Adjuvant therapy for cancer usually refers to surgery followed by chemo or radiotherapy to help to decrease the risk of cancer recurring.
  • 24. SURGICAL MANAGEMENT  MASTECTOMY: An operation to remove the breast is called mastectomy. There are five different types of mastectomy.  Simple or total mastectomy  Modified radical mastectomy  Radical mastectomy  Partial mastectomy  Nipple sparing mastectomy  Lymph node dissection  Cryotherapy  Breast reconstructive surgery  Prophylactic ovary removal
  • 25. SIMPLE / TOTAL MASTECTOMY  The surgeon removes the entire breast.  Does not perform axillary lymph node dissection.  No muscles are removed from beneath the breast.  It is appropriate for women with multiple or large areas of ductal carcinoma in situ (DCIS).
  • 26. MODIFIED RADICAL MASTECTOMY  The surgeon removes the entire breast.  Axillary lymph node dissection is performed, during which level I & II underarm lymph nodes are removed.  No muscles are removed from beneath the breast.  It is appropriate for women with invasive breast cancer.
  • 27. RADICAL MASTECTOMY  Entire breast should be removed.  Levels I, II & III of the underarm lymph nodes are removed.  The surgeon also removes the chest wall muscle under the breast.  It is recommended only when the breast cancer has spread to the chest muscles under the breast.
  • 28. CONT..  PARTIAL MASTECTOMY - It is the removal of cancerous part of the breast tissue and some normal tissue around it.  NIPPLE SPARING MASTECTOMY – All of the breast tissue is removed here, only the nipple is left alone.
  • 29.
  • 30. CONT..  CRYOSURGERY - Uses extreme cold to freeze and kill the cancer cells.  BREAST RECONSTRUCTIVE SURGERY – Rebuilding of the breast after mastectomy or sometimes lumpectomy. TYPES  Prosthetic implant  Autologous tissue reconstructions
  • 31.
  • 32. MEDICAL MANAGEMENT RADIATION THERAPY – most women receive radiation therapy after breast sparing surgery. Sometimes it can be used as primary treatment. Radiation destroys cancer cell that may remain in area. TYPES  External radiation  Internal radiation (Brachytherapy)
  • 33. CONT.. CHEMOTHERAPY –  Refers to use of cytotoxic drugs to destroy the cancer cell.  In some patient it is used preoperatively which decreases the size of the primary tumor, possibly permitting less extensive surgery.  Most common combinations of chemotherapy are –  CMF – Cyclophosphamide, Methotrexate, 5 fluorouracil  CEF – Cyclophosphamide, Epirubicin, 5 fluorouracil  Treatments are given every 3 – 4 weeks for 6 – 9 months.
  • 34. CONT.. HORMONAL THERAPY –  Recommended for all estrogen receptor positive patient.  Hormonal therapy blocks the source of estrogen thus promoting tumor regression.  Anastrozole, tamoxifen etc most commonly used. BIOTHERAPY –  Helps to strengthen the immune system to fight against the cancer.  Can be used alone or combined with chemotherapy.  Transtuzumab is a monoclonal antibody most commonly used.
  • 35. NURSING MANAGEMENT  PREOPERATIVE MANAGEMENT  POSEOPERATIVE MANAGEMENT
  • 36. NURSING DIAGNOSIS  Ineffective individual coping and compromised family coping related to diagnosis of cancer and surgical changes in breast as evidenced by facial mask of fear and frequent asking of questions.  Acute pain related to surgical incision as evidenced by verbalization of pain at surgical site.  Fluid electrolyte imbalance related to NPM status of patient / less intake by the patient or presence of surgical drainage system as evidenced by dry lip, dry mouth.
  • 37. CONT..  Impaired physical mobility related to weakness and muscular loss as evidenced by limitation in movement of upper extremity on surgical site.  High risk for infection related to surgical incision, presence of drainage system.  Risk for impaired skin integrity related to surgery or radiation therapy.  Disturbed body image related to mastectomy as evidenced by verbalization of concern about appearance & feelings of loss of femineity.
  • 38. POST MASTECTOMY EXERCISE HAND WALL CLIMBING  Stand facing wall with toes 6 – 12 inches from wall.  Bend elbows and place arms against wall at shoulder level.  Gradually move both hands up the wall parallel to each other until feel pain or pull in incision.
  • 39. CONT.. ROPE TURNING  Tie rope to the door handle.  Hold rope in hand of operated side,  Back from door until arm is extended away from body, parallel to floor.  Swing rope to make a circle as wide as possible.
  • 40. CONT.. ROD OR BROOMSTICK LIFTING  Grasp a rod with both hands, held about 2 feet apart.  Keeping the arm straight, raise the rod over the head.  Bend elbows to lower the rod behind the head.  Reverse maneuver, raising the rod above the head, then return to the starting position.
  • 41. CONT.. PULLEY TUGGING  Toss a light rope over curtain rod.  Hold the ends of the rope in each hand.  Slowly raise operated arm as comfortable by pulling down the rope on opposite side.  Reverse raise the unoperated arm by lowering the operated side.  Instead of rope towel can be used as it is used to clean the back of our body.
  • 42. CONT.. ELBOW CIRCLES  While on sitting or standing position. Put your right hand on right shoulder and left hand on left shoulder.  Raise the elbows until you feel a stretch and make circles with the elbows.  Start with small then make longer circles.  Change directions of circles and repeat 2 – 3 times.